Detalhe da pesquisa
1.
Virus Entry Inhibitors: Past, Present, and Future.
Adv Exp Med Biol
; 1366: 1-13, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412131
2.
Small-Molecule HIV Entry Inhibitors Targeting gp120 and gp41.
Adv Exp Med Biol
; 1366: 27-43, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412133
3.
The Genesis and Future Prospects of Small Molecule HIV-1 Attachment Inhibitors.
Adv Exp Med Biol
; 1366: 45-64, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412134
4.
Peptide-Based Dual HIV and Coronavirus Entry Inhibitors.
Adv Exp Med Biol
; 1366: 87-100, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412136
5.
Endogenous Peptide Inhibitors of HIV Entry.
Adv Exp Med Biol
; 1366: 65-85, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412135
6.
Peptide-Based HIV Entry Inhibitors.
Adv Exp Med Biol
; 1366: 15-26, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412132
7.
Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1.
N Engl J Med
; 379(7): 645-654, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30110589
8.
Monotherapy with a low-dose lipopeptide HIV fusion inhibitor maintains long-term viral suppression in rhesus macaques.
PLoS Pathog
; 15(2): e1007552, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30716118
9.
Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial.
Ann Intern Med
; 172(5): 297-305, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32040959
10.
PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Rynull Mice.
Biol Blood Marrow Transplant
; 24(2): 260-266, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29128556
11.
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.
Ann Intern Med
; 167(6): 384-393, 2017 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28828489
12.
HIV-1 Entry Inhibitors: A Review of Experimental and Computational Studies.
Chem Biodivers
; 15(10): e1800159, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30027572
13.
Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment.
Stat Med
; 36(5): 754-771, 2017 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27891651
14.
Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study.
Clin Infect Dis
; 63(1): 122-32, 2016 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27048747
15.
Ibalizumab in Multidrug-Resistant HIV - Accepting Uncertainty.
N Engl J Med
; 379(7): 605-607, 2018 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30110580
16.
Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor.
J Virol
; 89(22): 11457-72, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26339063
17.
Combination of long-acting HIV fusion inhibitor albuvirtide and LPV/r showed potent efficacy in HIV-1 patients.
AIDS Res Ther
; 13: 8, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26865854
18.
Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial.
AIDS Res Ther
; 13: 17, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27042193
19.
Pharmacokinetic interactions between BMS-626529, the active moiety of the HIV-1 attachment inhibitor prodrug BMS-663068, and ritonavir or ritonavir-boosted atazanavir in healthy subjects.
Antimicrob Agents Chemother
; 59(7): 3816-22, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25870057
20.
Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.
Crit Rev Microbiol
; 41(4): 473-87, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-24635642